{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:04:46Z","timestamp":1782601486803,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.oooo.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T19:05:02Z","timestamp":1458068702000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws"],"prefix":"10.1016","volume":"122","author":[{"given":"Sarina E.C.","family":"Pichardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P. Richard","family":"van Merkesteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2016.03.008_bib1","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","article-title":"Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases","volume":"25","author":"Lipton","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oooo.2016.03.008_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oooo.2016.03.008_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2016.03.008_bib5","first-page":"159","article-title":"Denosumab findings in metastatic breast cancer","volume":"8","author":"Stopeck","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.oooo.2016.03.008_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.oooo.2016.03.008_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.oooo.2016.03.008_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/14712591003604708","article-title":"Denosumab\u2014an emerging treatment for postmenopausal osteoporosis","volume":"10","author":"Lewiecki","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.oooo.2016.03.008_bib9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/13543780903048929","article-title":"RANKL inhibition for the management of patients with benign metabolic bone disorders","volume":"18","author":"Anastasilakis","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.oooo.2016.03.008_bib10","first-page":"2189","article-title":"Denosumab, osteoporosis, and prevention of fractures","volume":"361","author":"Kyrgidis","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2016.03.008_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.oooo.2016.03.008_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","article-title":"Antiresorptives and osteonecrosis of the jaw","volume":"12","author":"Yamashita","year":"2012","journal-title":"J\u00a0Evid Based Dent Pract"},{"key":"10.1016\/j.oooo.2016.03.008_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/adj.12217","article-title":"Denosumab and osteonecrosis of the jaws\u2014the pharmacology, pathogenesis and a report of two cases","volume":"59","author":"O'halloran","year":"2014","journal-title":"Aust Dent J"},{"key":"10.1016\/j.oooo.2016.03.008_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2016.03.008_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.oooo.2016.03.008_bib16","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3892\/ol.2014.1982","article-title":"Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: a meta-analysis of randomized controlled trials","volume":"7","author":"Wang","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.oooo.2016.03.008_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russel","year":"2008","journal-title":"Osteoporosis"},{"key":"10.1016\/j.oooo.2016.03.008_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib19","unstructured":"Prescribing information\u2014Prolia. Amgen Technology Ireland (ADL) Dublin, Ireland, 2010. Available at: http:\/\/pi.amgen.com\/united_states\/prolia\/prolia_pi.pdf."},{"key":"10.1016\/j.oooo.2016.03.008_bib20","unstructured":"Prescribing information\u2014Xgeva. Amgen Inc., Thousand Oaks, CA, 2010. Available at: http:\/\/pi.amgen.com\/united_states\/xgeva\/xgeva_pi.pdf"},{"key":"10.1016\/j.oooo.2016.03.008_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.oooo.2016.03.008_bib24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib25","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.jcms.2012.10.014","article-title":"Denosumab-osteonecrosis of the jaw: a new entity? Report of a case","volume":"41","author":"Pichardo","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2008.09.021","article-title":"Treating low- and medium-potency bisphosphonate related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases","volume":"107","author":"Alons","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2016.03.008_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","article-title":"Surgical management of bisphosphonate induced osteonecrosis of the jaws","volume":"39","author":"Williamson","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2016.03.008_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0901-5027(97)80012-4","article-title":"Treatment of chronic suppurative osteomyelitis of the mandible","volume":"26","author":"van Merkesteyn","year":"1997","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.03.008_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jbspin.2012.08.005","article-title":"Bisphosphonates and glucocorticoid-induced osteoporosis: efficacy and tolerability","volume":"80","author":"Lespessailles","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.oooo.2016.03.008_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.oooo.2016.03.008_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440316001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440316001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T15:24:51Z","timestamp":1567697091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440316001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2212440316001036"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2016.03.008","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}